GATA family transcriptional factors: emerging suspects in hematologic disorders. Issue 1 (December 2015)

• Record Type: Journal Article
• Authors: Gao, Juehua; Chen, Yi-Hua; Peterson, LoAnn
• Is Part Of: Experimental hematology & oncology. Volume 4:Issue 1(2014)
• Page Start: 1
• Page End: 7
• Publication Date: 2015-12
• Subjects: GATA -- Transcription factor -- Hematologic disorder; Hematology, Experimental -- Periodicals; Oncology, Experimental -- Periodicals; Hematologic Diseases -- Periodicals; Neoplasms -- Periodicals; 616.1502705
• DOI: 10.1186/s40164-015-0024-z
• Languages: English
• ISSNs: 2162-3619

Abstract

Abstract GATA transcription factors are zinc finger DNA binding proteins that regulate transcription during development and cell differentiation. The three important GATA transcription factors GATA1, GATA2 and GATA3 play essential roles in the development and maintenance of hematopoietic systems. GATA1 is required for the erythroid and megakaryocytic commitment during hematopoiesis. GATA2 is crucial for the proliferation and survival of early hematopoietic cells, and is also involved in lineage specific transcriptional regulation as the dynamic partner of GATA1. GATA3 plays an essential role in T lymphoid cell development and immune regulation. As a result, mutations in genes encoding the GATA transcription factors or alteration in the protein expression level or their function have been linked to a variety of human hematologic disorders. In this review, we summarized the current knowledge regarding the disrupted biologic function of GATA in various hematologic disorders.